Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05414955 · ClinicalTrials.gov registry record · NA
Boom-IBD Clinical Trial
A NA study, sponsored by Boomerang Medical.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT05414955 is a NA study that has completed, run by Boomerang Medical. The registered enrollment target is 40 participants.
The verdict
NCT05414955, a NA study, has completed, sponsored by Boomerang Medical.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
Feasibility study of neuromodulation in patients with IBD.
Interventions
- DEVICE Neuromodulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2022-10-01 |
| Est. Completion | 2024-12-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05414955
The ClinicalTrials.gov registry entry for NCT05414955 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boomerang Medical, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Neuromodulation is the first listed.
NCT05414955 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05414955 about?
NCT05414955 is a clinical study titled "Boom-IBD Clinical Trial". Feasibility study of neuromodulation in patients with IBD.
What is the current status of trial NCT05414955?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2022-10-01. Estimated completion is 2024-12-06.
What interventions are being tested in trial NCT05414955?
The interventions under investigation include: Neuromodulation (DEVICE).
Who is sponsoring clinical trial NCT05414955?
This trial is sponsored by Boomerang Medical, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.